July 7 (Reuters) - Vaccinex Inc:
* VACCINEX PROVIDES UPDATE OF POTENTIALLY PIVOTAL SIGNAL CLINICAL TRIAL IN HUNTINGTON’S DISEASE
* VACCINEX INC - REMAINS ON TRACK TO COMPLETE POTENTIALLY PIVOTAL SIGNAL TRIAL IN HD WITHIN ANTICIPATED TIME FRAME
* VACCINEX INC - CONTINUES TO ANTICIPATE THAT DATABASE LOCK WILL BE COMPLETED BY SEPTEMBER
* VACCINEX INC - PRIMARY EFFICACY DATA HAS BEEN COLLECTED FROM ALL SUBJECTS WHO COMPLETED STUDY EXCEPT FOR 2 SUBJECTS
* VACCINEX INC - IDENTIFIED PRIMARY AND SECONDARY ENDPOINTS FOR TWO RANDOMIZED ARMS OF SIGNAL TRIAL Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.